MARKET

DERM

DERM

Dermira
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.09
+0.05
+0.56%
After Hours: 8.09 0 0.00% 16:09 11/12 EST
OPEN
8.05
PREV CLOSE
8.05
HIGH
8.65
LOW
8.02
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
15.48
52 WEEK LOW
5.25
MARKET CAP
441.08M
P/E (TTM)
-1.7665
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DERM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

DERM News

  • Dermira to Participate in the Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day
  • Business Wire.1d ago
  • Edited Transcript of DERM earnings conference call or presentation 5-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • Business Wire.4d ago
  • Here's Why Dermira Stock Is Soaring Today
  • MotleyFool.com.4d ago

More

Industry

Biotechnology & Medical Research
+0.45%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About DERM

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and olumacostat glasaretil. Cimzia is an injectable biologic tumor necrosis factor-alpha inhibitor, or TNF inhibitor that is approved and marketed for the treatment of numerous inflammatory diseases spanning multiple medical specialties, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease, in multiple countries, including the United States. Glycopyrronium tosylate is a small molecule anticholinergic product for topical application for the treatment of primary axillary hyperhidrosis. Olumacostat glasaretil is a small molecule that targets sebum production following topical application for the treatment of acne.
More

Webull offers Dermira Inc (DERM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.